Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-011664
Filing Date
2021-06-03
Accepted
2021-06-03 21:03:11
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1725
2 poa.htm EX-24 6744
  Complete submission text file 0001567619-21-011664.txt   10116
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 64 STRYKER COURT BRIDGEWATER NJ 08807
Business Address
Seshadri Vishwas (Reporting) CIK: 0001865131 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 21994572